Zydus Lifesciences Limited (ZYDUSLIFE.NS) NSE

992.10

+17.1(+1.75%)

Updated at September 29 01:05PM

Currency In INR

Valuation

Market Cap883.06B
Enterprise Value885.63B
P/E Ratio21.8
PEG Ratio20.86
Price/Sales Ratio4.27
Price/Book Ratio4.16
Enterprise/Revenue4.28
Enterprise/EBITDA13.55

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.2
Operating Margin0.33

Management Effectiveness

Return On Assets0.12
Return On Equity0.2

Income Statement

Revenue232.42B
Revenue/Share232.15
Gross Profit169.04B
EBITDA68.95B
Net Income45.26B
Diluted EPS44.97

Balance Sheet

Total Cash78.08B
Total Cash/Share98.98
Total Debt32.13B
Total Debt/Equity0.13
Current Ratio1.89
Book Value Per Share262

Price History

52-Week Change-7.29
52-Week High1,088.85
52-Week Low795
Moving Average 50 Days994.46
Moving Average 200 Days945.35

Statistics

Average Volume968,031
Shares Outstanding1.01B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.11
Payout Ratio0
Last Split Factor5:1
Last Split DateOctober 06, 2015